case_images: PMC7734559_01
case_images: Immunohistochemistry of patient's tumor: (a) H&E, (b) Cytokeratin 14, (c) P63, and (d) EGFR. 200x.
case_images: 10.1177_2036361320977021-fig1.jpg
case_images: PMC7734559_01_10.1177_2036361320977021-fig1.jpg
case_images: fig1-2036361320977021
case_images: Immunohistochemical staining showed weak cytokeratin 14, p63 and GATA3 expression as well as strong staining for epidermal growth factor receptor (EGFR) (Figure 1).
case_images: Patient's tumor after three cycles of neoadjuvant AIM and surgical resection. Rare viable tumor cell amid extensive necrosis. H&E. 200x.
case_images: 10.1177_2036361320977021-fig2.jpg
case_images: PMC7734559_01_10.1177_2036361320977021-fig2.jpg
case_images: fig2-2036361320977021
case_images: The tissue pathology showed malignant spindle cell neoplasm with marked therapy effect consisting of >99% necrosis with rare scattered tumor cells present (Figure 2).